B-Cell Activation Pathways in Chronic GVHD

Track: BMT Tandem "Scientific" Meeting
Friday, February 13, 2015, 8:30 AM-10:00 AM
Seaport A-E (Manchester Grand Hyatt)
Stefanie Sarantopoulos, MD, PhD , Duke Adult Blood and Marrow Transplant Program, Duke University, Durham, NC
Disclosures:
S. Sarantopoulos, pharmacyclics honorarium, ad hoc advisory board for chronic gvhd trial using ibrutinib: Advisory Board
Rigel, nothing financial, we are testing fostamatinib in preclinical studies, rigel may provide drug if we go to clinical trial: fostamatinib supply for lab and potential clinical trial